TiN pull-back and cleaning composition
10170296 ยท 2019-01-01
Assignee
Inventors
Cpc classification
H01L21/02063
ELECTRICITY
C11D2111/22
CHEMISTRY; METALLURGY
C09K13/00
CHEMISTRY; METALLURGY
C11D17/041
CHEMISTRY; METALLURGY
International classification
C09K13/00
CHEMISTRY; METALLURGY
C11D11/00
CHEMISTRY; METALLURGY
H01L21/311
ELECTRICITY
H01L21/02
ELECTRICITY
H01L21/3213
ELECTRICITY
Abstract
The present invention relates to a novel composition that may be used to control the etching rate of TIN with respect to W, and remove any residues from the surface, e.g. organic or inorganic residues that could contain fluorine (F), which composition comprises a) an aliphatic or aromatic sulfonic acid; b) one or more inhibitor(s); c) an aprotic solvent; d) a glycol ether; and e) water. The present invention also relates to a kit comprising said composition in combination with an oxidant and optionally a stabilizer of the oxidant, and the use thereof.
Claims
1. A composition, comprising the following components a)-f), based on total weight of the composition: a) 0.05-4 wt. % of an aliphatic or aromatic sulfonic acid; b) 0.1 to 10 wt % of an inhibitor selected from the group consisting of imidazolidinones, imidazolidines, and 2-oxazolidinones; c) 5 to 50 wt % of an aprotic solvent; d) 1 to 60 wt % of a glycol ether; e) water; and an oxidant, wherein a weight ratio of the aprotic solvent to the water is from 1:10 to 2:1 and wherein the oxidant is present in a volume ratio of components a) to e)to the oxidant ranging from 65:1 to 8:1.
2. The composition according to claim 1, wherein said aliphatic or aromatic sulfonic acid is selected from the group consisting of: alkyl sulfonic acid, 3-(N-morpholino)propane sulfonic acid, 2-(N-morpholino)ethanesulfonic acid, N-cyclohexyl-2-aminoethanesulfonic acid, 3-[4-(2-hydroxyethyl)-1-piperazinyl]propanesulfonic acid, N-cyclohexyl-3-aminopropanesulfonic acid, and mixtures thereof.
3. The composition according to claim 2, wherein the aliphatic or aromatic sulfonic acid is present in the composition in an amount ranging from 0.1 to 1 wt %, based on the total weight of the composition.
4. The composition according to claim 1, wherein said inhibitor is selected from the group consisting of imidazolidinones, imidazolidines, and mixtures thereof.
5. The composition according to claim 1, wherein said aprotic solvent is selected from the group consisting of dimethyl sulfoxide, sulfolane, propylene carbonate, dimethylacetamide, N-methyl-2-pyrrolidone, dimethylformamide, and mixtures thereof.
6. The composition according to claim 5, wherein the aprotic solvent is present in the composition in an amount ranging from 20 to 45 wt %, based on the total weight of the composition.
7. The composition according to claim 1, wherein said glycol ether is selected from the group consisting of butyl diglycol, 2-hexoxy-1-ethanol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, 2-(naphthalene-6-yloxy)polyethoxyethanol, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monopropyl ether, diethylene glycol monoisopropyl ether diethylene glycol monobutyl ether, diethylene glycol monoisobutyl ether, diethylene glycol monobenzyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, triethylene glycol monomethyl ether, triethylene glycol dimethyl ether, polyethylene glycol monomethyl ether, diethylene glycol methyl ethyl ether, triethylene glycol ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, propylene glycol monomethyl ether, propylene glycol dimethyl ether, propylene glycol monobutyl ether, propylene glycol, monoproply ether, dipropylene glycol monomethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoisopropyl ether, dipropylenemonobutyl ether, dipropylene glycol diisopropyl ether, tripropylene glycol monomethyl ether, 1-methoxy-2-butanol, 2-methoxy-1-butanol, 2-methoxy-2-methylbutanol, 1,1-dimethoxyethane, 2-(2-butoxyethoxy) ethanol, and mixtures thereof.
8. The composition according to claim 1, further comprising a stabilizer selected from the group consisting of amine-N-oxide, citric acid, 1-hydroxyethane 1,1-diphosphonic acid, glycolic acid, lactic acid, hydroxybutyric acid, glyceric acid, malic acid, tartaric acid, malonic acid, succinic acid, glutaric acid, maleic acid, and mixtures thereof.
9. The composition according to claim 8, wherein the stabilizer is present in the composition in an amount ranging from 0.01 to 0.5 wt %, based on the total weight of the composition.
10. The composition according to claim 1, wherein the weight ratio of the aprotic solvent to the water is from 1:8 to 1:1 and wherein the oxidant is present in a volume ratio of components a) to e) to the oxidant ranging from 65:1 to 12:1.
11. The composition according to claim 1, wherein said oxidant is selected from the group consisting of hydrogen peroxide, peroxide urea, peroxydisulfuric acid, ammonium persulfate, peroxymonosulfuric acid, pyrosulfuric acid, and ozone.
12. The composition according to claim 1, wherein the aprotic solvent is selected from the group consisting of dimethyl sulfoxide (DMSO), dimethylacetamide (DMAc), dimethylformamide (DMF), and mixtures thereof.
13. The composition according to claim 12, wherein said oxidant is selected from the group consisting of hydrogen peroxide, peroxide urea, peroxydisulfuric acid, ammonium persulfate, peroxymonosulfuric acid, pyrosulfuric acid, and ozone.
14. A removal process, comprising: removing organic and/or inorganic residues from a surface by contacting said surface with the composition according to claim 1.
15. The process according to claim 14, wherein said oxidant is selected from the group consisting of hydrogen peroxide, peroxide urea, peroxydisulfuric acid, ammonium persulfate, peroxymonosulfuric acid, pyrosulfuric acid, and ozone.
16. The process according to claim 14, wherein the organic and/or inorganic residues comprise fluorine.
17. The process according to claim 14, further comprising: etching TiN from the surface in the presence of tungsten.
18. An etching process, comprising: etching TiN from a surface by contacting said surface with the composition according to claim 1, in the presence of another metal.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
(8) While the present disclosure is susceptible of embodiment in various forms, there will hereinafter be described a presently preferred embodiment with the understanding that the present disclosure is to be considered an exemplification of the disclosure and is not intended to limit the disclosure to the specific embodiment illustrated.
(9) In one embodiment of the present application, a composition is prepared by mixing a) an aliphatic or aromatic sulfonic acid; b) one or more inhibitor(s); c) an aprotic solvent; d) a glycol ether; and e) water in any order. The composition may be used for the preparation of a formulation in which the TiN and W etch rates can be tuned, as well as organic and/or inorganic residues (optionally containing F) can be removed, during the semiconductor/IC production processes. To this end, an oxidant can be added to the composition and optionally a stabilizer of said oxidant can be added.
(10) Accordingly, in another embodiment of the present application, a formulation is prepared by mixing a) an aromatic or aliphatic sulfonic acid; b) one or more inhibitor(s); c) an aprotic solvent; d) a glycol ether; and e) water in any order, followed by the addition of an oxidant, and optionally a stabilizer of said oxidant.
(11) Then, blanket wafers (tungsten, TiN, low-k) or patterned wafer to be treated are broken into coupons, and then brought into contact with the formulations as prepared.
(12) As illustrated in
(13) The inhibitor(s) may be selected from the class of compounds known as imidazolidinones (class a), imidazolidines (class b), or 2-oxazolidinones (class c).
(14) a) Imidazolidinones
(15) ##STR00001## R.sub.1, R.sub.2=H, C.sub.nH.sub.2n+1, C.sub.6H.sub.5, CH.sub.2C.sub.6H.sub.5, OH, C.sub.nH.sub.2nOH with n=1-10, C(O)NR.sub.3R.sub.4, NR.sub.3R.sub.4, C(O)OR.sub.5 R.sub.3, R.sub.4=H, C.sub.nH.sub.2n+1, C.sub.6H.sub.5, CH.sub.2C.sub.6H.sub.5, C(O)OH, OH, C.sub.nH.sub.2nOH with n=1-10 R.sub.5=H, C.sub.nH.sub.2n+1, CH.sub.2C.sub.6H.sub.5, C.sub.6H.sub.5, C.sub.nH.sub.2nOH with n=1-10, NR.sub.3R.sub.4
(16) b) Imidazolidines
(17) ##STR00002## R.sub.1, R.sub.2, R.sub.3=H, C.sub.nH.sub.2n+1, C.sub.6H.sub.5, CH.sub.2C.sub.6H.sub.5, OH, C.sub.nH.sub.2nOH with n=1-10, C(O)NR.sub.4R.sub.5, NR.sub.4R.sub.5, C(O)OR.sub.6 R.sub.4, R.sub.5=H, CnH.sub.2n?1, C.sub.6H.sub.5, CH.sub.2C.sub.6H.sub.5, C(O)OH, OH, C.sub.nH.sub.2nOH with n=1-10 R.sub.6=H, CnH.sub.2n+1, CH.sub.2C.sub.6H.sub.5, C.sub.6H.sub.5, CnH.sub.2nOH with n=1-10, NR.sub.4R.sub.5
(18) c) 2-Oxazolidinones
(19) ##STR00003##
(20) R.sub.1=H, CnH.sub.2n+1, C.sub.6H.sub.5, CH.sub.2C.sub.6H.sub.5, OH, C.sub.nH.sub.2nOH with n=1-10, C(O)NR.sub.2R.sub.3, NR.sub.2R.sub.3, C(O)OR.sub.4 R.sub.2, R.sub.3=H, CnH.sub.2n+1, ?C.sub.6H.sub.5, CH.sub.2C.sub.6H.sub.5, C(O)OH, OH, C.sub.nH.sub.2nOH with n=1-10 R.sub.4=H, CnH.sub.2n+1, CH.sub.2C.sub.6H.sub.5, C.sub.6H.sub.5, CnH.sub.2nOH with n=1-10, NR.sub.2R.sub.3
(21) The inhibitor may be for instance ethylene urea, N-(2-Hydroxyethyl)ethylene urea, 1-(2-Hydroxyethyl)-2-imidazolidinone, or 2-oxazolidinone, 3-methyl-2oxazolidone, and their derivatives. The inhibitors may also be a polyethyleneimine or polypropyleneimine.
(22) The inhibitor(s) may be present in the composition of this invention in an amount ranging from 0.1 to 10 wt %, such as 2.7 wt %, based on the total weight of the composition.
(23) While not wishing to be bound by this theory, it is believed that the adsorption control may be achieved by the coordinate bonding 31 of the inhibitor(s) to the surface of the metal plug, as illustrated for tungsten in
(24) The glycol ether may be present in the composition of this invention in an amount ranging from 1 to 60%, based on the total weight of the composition.
(25) In the composition of the present disclosure, the solvent and water ratio is from 1:10 to 2:1, preferably from 1:8 to 1:1, most preferably from 1:5 to 1:1.
(26) As illustrated in
TiN+H.sub.2O+2H.sub.2O.sub.2.fwdarw.NH.sub.3(g)+H.sub.2TiO.sub.3(aq)+O.sub.2(g)(chemical equation 1) To enhance the TiN etching rate, the right forward direction for the above equation is preferable.
(27) While not wishing to be bound by this theory, it is known to those skilled in the art that the produced metatitanic acid (H.sub.2TiO.sub.3) has a complex structure and can readily react with water to give a host of Ti(IV) compounds in (partly) aqueous solutions. Depending on the pH of the solution, an equilibrium is established which contains the compounds depicted in chemical equation 2, in addition to a myriad of other structures, such as oligomers and nanotubes consisting of Ti(IV) species of various hydration number.
(28) ##STR00004##
(29) Below, we show that adding a sulfonic acid to the solution, increases the etch rate of the TiN. We attribute this to a shift in the equilibrium of chemical equation 1, by the coordination of the sulfonic acid to the titanium(IV), removing it from the right-hand side of the equation and shifting the equilibrium to give an enhanced etch rate of the titanium. The structure formed by the exchange of a hydroxyl ligand with a sulfonic acid ligand is depicted in
(30) The aromatic or aliphatic sulfonic acids may be used to adjust the pH value and to control lower W etching rate. In addition, said sulfonic acids may also contribute to the removal of metal-containing residues, by the formation of stabilizing coordination bonds as described earlier. Further, said sulfonic acids do not damage low-k materials and are good stabilizers of H.sub.2O.sub.2.
(31) The aliphatic or aromatic sulfonic acid may be selected from alkyl sulfonic acid (such as methanesulfonic acid, ethanesulfonic acid, propanesulfonic acid, butanesulfonic acid and hexanesulfonic acid), 3-(N-morpholino)propane sulfonic acid (MOPS), 2-(N-morpholino)ethanesulfonic acid (MES), N-cyclohexyl-2-aminoethanesulfonic acid (CHES), 3-[4-(2-hydroxyethyl)-1-piperazinyl]propanesulfonic acid (HEPPS) or N-cyclohexyl-3-aminopropanesulfonic acid (CAPS), or a mixture thereof.
(32) The aliphatic or aromatic sulfonic acid may be present in the composition of this invention in an amount ranging from 0.05 to 4 wt %, preferably from 0.1 to 1 wt %, most preferably from 0.1 to 0.5 wt %, such as 0.3 wt %, based on the total weight of the composition.
(33) The aprotic solvent may be selected from dimethyl sulfoxide (DMSO), sulfolane, propylene carbonate, dimethylacetamide (DMAc), N-methyl-2-pyrrolidone (NMP) or dimethylformamide (DMF), or a mixture thereof.
(34) The aprotic solvent may be present in the composition of this invention in an amount ranging from 5 to 50 wt %, preferably from 20 to 45 wt %, most preferably from 30 to 40 wt %, such as 35 wt %, based on the total weight of the composition.
(35) In another embodiment of the present invention, an oxidant such as hydrogen peroxide (H.sub.2O.sub.2), peroxide urea, peroxydisulfuric acid, ammonium persulfate, peroxymonosulfuric acid, pyrosulfuric acid, ozone, particularly H.sub.2O.sub.2, may be added to the composition comprising a) analiphatic or aromatic sulfonic acid; b) one or more inhibitor(s); c) an aprotic solvent; d) a glycol ether; and e) water, to form a formulation.
(36) The oxidant may be added in a volume ratio (the composition comprising components a) to e) to the oxidant) ranging from 65:1 to 8:1 (about from 0.5 to 3 wt %), preferably from 65:1 to 12:1 (about from 0.5 to 2.5 wt %), most preferably from 65:1 to 15:1 (about from 0.5 to 2 wt %), such as 32:1 (about 1 wt %).
(37) Optionally, a stabilizer of the oxidant may be added to the formulation.
(38) The stabilizer may be selected from amine-N-oxide (e.g. N-methylmorpholine N-oxide, pyridine-N-oxide), citric acid, 1-hydroxyethane 1,1-diphosphonic acid (HEDP), N-(hydroxyethyl)-ethylenediaminetriacetic acid (HEDTA), glycolic acid, lactic acid, hydroxybutyric acid, glyceric acid, malic acid, tartaric acid, malonic acid, succinic acid, glutaric acid, maleic acid, or a mixture thereof.
(39) The stabilizer may be present in the composition of this invention in an amount ranging from 0.01 to 0.5 wt %, preferably from 0.01 to 0.1 wt %, most preferably from 0.01 to 0.05 wt %, such as 0.05 wt %, based on the total weight of the composition.
(40) In another embodiment of the present application, a kit is provided. Said kit is constituted of A) a composition comprising: a) an aliphatic or aromatic sulfonic acid; b) one or more inhibitor(s); c) an aprotic solvent; d) a glycol ether; and e) water; and B) an oxidant, and optionally a stabilizer of said oxidant.
(41) The kit may be used for tuning of the etch rates of W and TiN, respectively, and the removal of organic and/or inorganic residue (optionally containing F) from the wafer, during the semiconductor/IC production processes.
(42) The following Experiments and Examples are conducted to illustrate the etching and etching rate of TiN and W plug respectively, and show the removal of F-containing residue.
(43) Experiments:
(44) A. Etching Rates Experiment:
(45) Step 1. Blanket wafers (tungsten, TiN, low-k), or patterned wafer were selected from commercial sources. Step 2. Wafers were broken into smaller coupons 51, as depicted in
The Etching Rate=(330?300)/10=3 ?/min
B. Patterned wafers surface residues composition evaluation The steps are the same as in A, but Steps 3, 10 and 11 were not performed. The elemental abundance was determined by XPS, as depicted in
EXAMPLES
(46) The following Examples are given to allow better understanding of the disclosure. These Examples are not to be construed as narrowing the scope of the disclosure in any aspect.
(47) All percentage data in the present description are percent by weight, based on the total weight of the composition, except for that the oxidant is added in a volume ratio as the composition comprising components a) to e) to the oxidant, and calculated to be percent by weight. It goes without saying here that the amounts of the added components a) to e) in a composition add up to 100%.
(48) Various Examples were performed following the steps described in the foregoing as summarized hereunder to illustrate the present disclosure and the comparison between the prior art and the present disclosure.
Examples 1-4
(49) In Examples 1-4, citric acid was used as organic acid, and in Examples 3-4, Ablumine O (a mixture of 1-hydroxyethyl-2-alkylimidazolines) was used as an inhibitor. The balance is water.
(50) TABLE-US-00001 TABLE 1 Example 1 Example 2 Example 3 Example 4 Citricacid 0.05 0 0.05 0.1 BDG 10 10 40 40 NMP 10 10 10 10 1-hydroxyethyl-2- 0 0 0.05 0.05 alkylimidazolines Balance 79.95 80 49.9 49.85 Hydrogen peroxide 0.50 0.50 0.50 0.50 TiN E/R (?/min) 2.5 2.5 0.2 0.1 W E/R (?/min) 28.0 43.0 4.0 2.0
(51) The results in Table 1 show that in the absence of an organic acid like citric acid (Example 2), the undesired W E/R was extremely high. Furthermore, the addition of Ablumine O as a W inhibitor (Examples 3-4) showed that suppression of W E/R simultaneously resulted in a significant TiN E/R suppression.
Example 5
(52) In Example 5, NMP was replaced with DMSO. The balance is water.
(53) TABLE-US-00002 TABLE 2 Example 5 Citricacid 0.05 BDG 40 DMSO 10 1-hydroxyethyl-2- 0.05 alkylimidazolines Balance 49.9 Hydrogen peroxide 0.50 TiN E/R (?/min) 0.2 W E/R (?/min) 4.0
(54) The results in Table 2 show that change of solvent from NMP to DMSO did not change the W/TiN E/R ratio.
Examples 6-10
(55) In Examples 6-10, citric acid was replaced with methanesulfonic acid and hydrogen peroxide was added. The results are summarized in Table 3. The balance is water.
(56) TABLE-US-00003 TABLE 3 Example 6 Example 7 Example 8 Example 9 Example 10 Methanesulfonicacid 0.05 0.1 0.1 0.1 0.1 BDG 40 20 10 10 10 DMSO 10 30 10 10 10 1-hydroxyethyl-2- 0.05 0.05 0.05 0.05 0.05 alkylimidazolines balance 49.9 49.85 79.85 79.85 79.85 Hydrogen peroxide 0.50 0.50 0.50 0.50 1.00 TiN E/R (?/min) 0.7 0.8 0.8 0.8 1.2 W E/R (?/min) 4.0 4.0 2.0 2.0 2.0
(57) The results in Table 3 show that use of methanesulfonic acid instead of citric acid and the addition of hydrogen peroxide, enhanced the TiN E/R without simultaneously increasing W E/R, and not only afforded more control over the etch ratio than citric acid, but also improved the W/TiN E/R ratio, which is desirable in IC production processes.
Examples 11-19
(58) In Examples 11-19, Ablumine O (a mixture of 1-hydroxyethyl-2-alkylimidazolines) was replaced with 2-imidazolidinone as a W-inhibitor, and hydrogen peroxide was added as an oxidizer. The results are summarized in Table 4. The balance is water.
(59) TABLE-US-00004 TABLE 4 Example 11 Example 12 Example 13 Example 14 Example 15 Methanesulfonicacid 0.1 0 0.1 0.1 0.1 BDG 10 10 10 10 10 DMSO 10 10 10 10 10 2-imidazolidinone 0.5 0.5 1 2 3 Balance 79.4 79.5 78.9 77.9 76.9 Hydrogen peroxide 1.00 1.00 1.00 1.00 1.00 TiN E/R (?/min) 1.4 0.5 1.3 1.3 1.2 W E/R (?/min) 13.0 13.0 10.0 8.0 8.0 Example 16 Example 17 Example 18 Example 19 Methanesulfonicacid 0.1 0.1 0.1 0.3 BDG 20 35 25 25 DMSO 40 25 35 35 2-imidazolidinone 3 3 3 3 Balance 36.9 36.9 36.9 36.7 Hydrogen peroxide 1.00 1.00 1.00 1.00 TiN E/R (?/min) 0.4 1.3 0.7 2 W E/R (?/min) 5.0 4.0 5.4 5.0
(60) The results in Table 4, specifically Examples 12, 13, 14 and 15, show that the use of sufficient 2-imidazolidinone can significantly lower the etch rate on W whilst retaining the etch rate on TiN. Examples 16, 17 and 18 show that changing the ratio and concentration of solvents BDG and DMSO will also change this selectivity, with Example 17 showing the lowest etch rate on W whilst keeping a high etch rate on TiN. In addition, the mixture of Example 17, without added hydrogen peroxide, showed an etch rate of low-k material of 0 ?/min (k=2.6) and 0.1 ?/min (k=2.3) at 60? C., respectively.
Examples 20-31
(61) In Examples 20-31, other suitable organic acids and W inhibitors that may be used in the present disclosure were tested as summarized in Table 5. The balance is water.
(62) TABLE-US-00005 TABLE 5 Example 20 Example 21 Ethanesulfonic acid 0.3 3-(N-morpholino)- 0.1 propanesulfonic acid Methanesulfonic acid 0.5 BDG 25 BDG 25 DMSO 35 DMSO 35 2-imidazolidinone 3.3 2-imidazolidinone 3.5 balance 36.4 balance 35.9 Hydrogen peroxide 1.00 Hydrogen peroxide 1.00 TiN E/R (?/min) 0.7 TiN E/R (?/min) 1.8 W E/R (?/min) 5.0 W E/R (?/min) 6.1 Example 22 Example 23 2-(N-morpholino)- 0.1 Methanesulfonicacid 1.0 ethanesulfonicacid Methanesulfonicacid 0.8 BDG 25 BDG 30 DMSO 35 DMSO 20 2-imidazolidinone 3.5 Lutropur G35 0.05 balance 35.6 balance 48.95 Hydrogen peroxide 1.00 Hydrogen peroxide 1.00 TiN E/R (?/min) 1.6 TiN E/R (?/min) 0.7 W E/R (?/min) 6.5 W E/R (?/min) 4.5 Example 24 Example 25 Methanesulfonicacid 1.0 Methanesulfonicacid 1.0 BDG 30 BDG 30 DMSO 20 DMSO 20 Lutropur G20 0.5 Lutropur G100 0.5 balance 48.5 balance 48.5 Hydrogen peroxide 1.00 Hydrogen peroxide 1.00 TiN E/R (?/min) 0.6 TiN E/R (?/min) 0.8 W E/R (?/min) 8.0 W E/R (?/min) 10.0 Example 26 Example 27 Methanesulfonicacid 1.0 Methanesulfonicacid 0.5 BDG 30 BDG 20 DMSO 20 DMSO 30 Lutropur FG 0.5 Lutropur G35 0.05 2-imidazolidinone 3.5 balance 48.5 balance 45.95 Hydrogen peroxide 1.00 Hydrogen peroxide 1.00 TiN E/R (?/min) 0.7 TiN E/R (?/min) 0.8 W E/R (?/min) 14.4 W E/R (?/min) 3.0 Example 28 Example 29 Methanesulfonicacid 0.1 Methanesulfonicacid 0.3 BDG 30 BDG 30 DMSO 20 DMSO 20 Citricacid 0.05 HEDP 0.05 2-imidazolidinone 3.5 2-imidazolidinone 3.5 balance 46.35 balance 46.15 Hydrogen peroxide 1.00 Hydrogen peroxide 1.00 TiN E/R (?/min) 0.3 TiN E/R (?/min) 0.3 W E/R (?/min) 5.7 W E/R (?/min) 1.3 Example 30 Example 31 Methanesulfonicacid 0.8 Methanesulfonicacid 0.5 BDG 30 BDG 25 DMSO 20 DMSO 35 HEDP 0.05 N-Methylmorpholine 0.08 N-oxide 2-imidazolidinone 3.5 2-imidazolidinone 3 balance 45.65 balance 36.42 Hydrogen peroxide 1.00 Hydrogen peroxide 1.00 TiN E/R (?/min) 0.5 TiN E/R (?/min) 1.8 W E/R (?/min) 1.6 W E/R (?/min) 5.4
(63) From the results in the above Tables, it is obvious that the inhibitor(s) used allows for control over the etch rate ratio of TiN and W. In addition,
(64) In the present disclosure, the words a or an are to be taken to include both the singular and the plural. Conversely, any reference to plural items shall, where appropriate, include the singular.
(65) From the foregoing, it will be observed that numerous modifications and variations can be effectuated without departing from the true spirit and scope of the novel concepts of the present disclosure. It is to be understood that no limitation with respect to the illustrated specific embodiments or Examples is intended or should be inferred. The disclosure is intended to cover by the appended claims all such modifications as fall within the scope of the claims.